I: Insilico Medicine 10 Years of AI Drug Discovery Innovation
Revolutionizing Drug Development
“This first drug candidate that’s going to Phase 2 is a true highlight of our end-to-end approach to bridge biology and chemistry with deep learning.
This is a significant milestone not only for us, but for everyone in the field of AI-accelerated drug discovery.”
By Alex Zhavoronkov, PhD, Founder and CEO of Insilico Medicine
…